Evidence map›Paper›PMID 41392534›Full record

ArticleJournal of extracellular vesicles2025

Calibration of Flow Cytometers Enables Reproducible Measurements of Extracellular Vesicle Concentrations and Reference Range Establishment.

Britta A Bettin, Bo Li, Kim Falkena, Ton G van Leeuwen, Christian Gollwitzer, Zoltán Varga, Nadine Ajzenberg, Jovan P Antovic, Pascale Berckmans, Edit I Buzas and 28 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Measurement of extracellular vesicles using flow cytometry: friend or foe?Research and practice in thrombosis and haemostasis · 2026
    Article
  2. Review
  3. The Dilution Paradox in Extracellular Vesicle Flow Cytometry.Journal of extracellular vesicles · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Britta A BettinLaboratory of Experimental Clinical Chemistry, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3353-2129
Bo LiLaboratory of Experimental Clinical Chemistry, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-6129-321X
Kim FalkenaExometry B.V., Amsterdam, The Netherlands.
Ton G van LeeuwenBiomedical Engineering & Physics, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5642-1133
Christian GollwitzerPhysikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.ORCID https://orcid.org/0000-0002-6437-8825
Zoltán VargaHUN-REN Research Centre for Natural Sciences, Magyar tudósok körútja 2., H-1117 Budapest, Hungary and Department of Physical Chemistry and Materials Science, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.ORCID https://orcid.org/0000-0002-5741-2669
Nadine AjzenbergUniversité Paris Cité, INSERM U1148, LVTS, Paris, France.ORCID https://orcid.org/0000-0001-8960-1766
Jovan P AntovicCoagulation, Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Pascale BerckmansEnvironmental Intelligence Unit, Flemish Institute for Technological Research, Mol, Belgium.ORCID https://orcid.org/0009-0008-5858-0892
Edit I BuzasDepartment of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.ORCID https://orcid.org/0000-0002-3744-206X
Randy P CarneyDepartment of Biomedical Engineering, University of California, Davis, California, USA.ORCID https://orcid.org/0000-0001-8193-1664
Sean CookTranslational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland, USA.
Françoise Dignat-GeorgeAix Marseille Univ, INSERM 1263, INRAe 1260, C2VN, Marseille, France.ORCID https://orcid.org/0000-0001-7006-4462
Dorothee FailleUniversité Paris Cité, INSERM U1148, LVTS, Paris, France.ORCID https://orcid.org/0000-0003-4414-739X
Bernd GiebelInstitute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0003-2446-948X
Jennifer C JonesTranslational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-9488-7719
Yohan KimDepartment of Urology, Mayo Clinic, Rochester, Minnesota, USA.
Romaric LacroixAix Marseille Univ, INSERM 1263, INRAe 1260, C2VN, Marseille, France.ORCID https://orcid.org/0000-0002-5756-470X
Joanne LanniganFlow Cytometry Support Services, LLC, USA.ORCID https://orcid.org/0000-0002-3981-8681
Fabrice LucienDepartment of Urology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-6149-345X
Katariina MaaninkaEV group and EV core, Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0000-0001-6341-3871
Erika G Marques de MenezesVitalant Research Institute, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-3273-6755
Annette MeyerEuropean Center for Single Cell Solutions ESS, BD Biosciences, Heidelberg, Germany.
Rachel R MizenkoDepartment of Biomedical Engineering, University of California, Davis, California, USA.ORCID https://orcid.org/0000-0002-9991-8799
Inge NelissenEnvironmental Intelligence Unit, Flemish Institute for Technological Research, Mol, Belgium.ORCID https://orcid.org/0000-0002-1248-3463
John NolanScintillon Institute, San Diego, California, USA.
Philip J NorrisVitalant Research Institute, San Francisco, California, USA.
Desmond PinkNanostics Inc. Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0002-7543-3199
Sumeet PoudelBiosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.ORCID https://orcid.org/0009-0006-7617-9838
Stéphane RobertAix Marseille Univ, INSERM 1263, INRAe 1260, C2VN, AMUTICYT Core Facility, Marseille, France.
Pia R-M SiljanderEV group and EV core, Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0000-0003-2326-5821
Vera A TangUniversity of Ottawa Flow Cytometry & Virometry Core Facility, Faculty of Medicine, Ottawa, Canada.ORCID https://orcid.org/0000-0003-3930-9139
Tobias TertelInstitute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0001-8659-8610
Tina Van Den BroeckMedical and Scientific Affairs, BD Biosciences, Erembodegem, Belgium.
Lili WangBiosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.ORCID https://orcid.org/0000-0003-2456-898X
Joshua A WelshTranslational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-1097-9756
Rienk NieuwlandLaboratory of Experimental Clinical Chemistry, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5671-3400
Edwin van der PolLaboratory of Experimental Clinical Chemistry, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-9497-8426

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
EMPIR program 18HLT01: METVES IIEuropean Union's Horizon 2020 Research and Innovation Program VIDI project 19724NCI NIH HHS P30 CA093373
6 · The paper itself

Abstract

The concentration of cells is a key component of modern blood tests. Given the biomarker potential of extracellular vesicles (EVs) in blood, we aimed to establish reference ranges for blood cell-derived EVs using flow cytometry. To address the orders-of-magnitude variability in reported EV concentrations between different flow cytometers (FCMs), we first validated a calibration methodology to enable reproducible EV concentration measurements. The methodology was evaluated in an interlaboratory comparison study and shows that calibration reduces the median absolute deviation of EV concentrations measured on 25 different FCMs from 67 % to 25 %-31 %. The calibration methodology was then used to determine reference ranges of erythrocyte-, leukocyte-, and platelet-derived EVs in human blood plasma in a cohort of healthy individuals (n = 224). This study demonstrates that calibration enables comparable concentration measurements of blood cell-derived EVs, thereby bringing EVs one step closer to clinical applications.

Indexed as

Extracellular VesiclesFlow CytometryAdultBiomarkersBlood PlateletsCalibrationErythrocytesFemaleHumansLeukocytesMaleMiddle AgedReference ValuesReproducibility of ResultsBiomarkersblood plasmacalibrationextracellular vesiclesflow cytometryreference rangesreproducibilitystandardization

Identifiers

PMID41392534
PMCPMC12703049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.